Details

Autor(en) / Beteiligte

• Smyk, Marta
• Geremek, Maciej
• Ziemkiewicz, Kamila
• Gambin, Tomasz
• Kutkowska-Kaźmierczak, Anna
• Kowalczyk, Katarzyna
• Plaskota, Izabela
• Wiśniowiecka-Kowalnik, Barbara
• Bartnik-Głaska, Magdalena
• Niemiec, Magdalena
• Grad, Dominika
• Piotrowicz, Małgorzata
• Gieruszczak-Białek, Dorota
• Pietrzyk, Aleksandra
• Crowley, T Blaine
• Giunta, Victoria
• McGinn, Daniel E
• Zackai, Elaine H
• Tran, Oanh
• Emanuel, Beverly S
• McDonald-McGinn, Donna M
• Nowakowska, Beata A

Titel

Coexisting Conditions Modifying Phenotypes of Patients with 22q11.2 Deletion Syndrome

Ist Teil von

• Genes, 2023-03, Vol.14 (3), p.680

Ort / Verlag

Switzerland: MDPI AG

Erscheinungsjahr

2023

Quelle

MEDLINE

Beschreibungen/Notizen

• 22q11.2 deletion syndrome (22q11.2DS) is the most common genomic disorder with an extremely broad phenotypic spectrum. The aim of our study was to investigate how often the additional variants in the genome can affect clinical variation among patients with the recurrent deletion. To examine the presence of additional variants affecting the phenotype, we performed microarray in 82 prenatal and 77 postnatal cases and performed exome sequencing in 86 postnatal patients with 22q11.2DS. Within those 159 patients where array was performed, 5 pathogenic and 5 likely pathogenic CNVs were identified outside of the 22q11.2 region. This indicates that in 6.3% cases, additional CNVs most likely contribute to the clinical presentation. Additionally, exome sequencing in 86 patients revealed 3 pathogenic (3.49%) and 5 likely pathogenic (5.81%) SNVs and small CNV. These results show that the extension of diagnostics with genome-wide methods can reveal other clinically relevant changes in patients with 22q11 deletion syndrome.